Cleared Traditional

K840018 - DPC ACTH KIT

K840018 is an FDA 510(k) clearance for DPC ACTH KIT, manufactured by Diagnostic Products Corp.. The device is a Class 2 Chemistry device with product code CKG cleared through the Traditional 510(k) pathway after a 78-day FDA review.

K840018 · Diagnostic Products Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1984
Decision
78d
Days
Class 2
Risk

K840018 is an FDA 510(k) clearance for the DPC ACTH KIT. Classified as Radioimmunoassay, Acth (product code CKG), Class II - Special Controls.

Submitted by Diagnostic Products Corp. (Mchenry, US). The FDA issued a Cleared decision on March 23, 1984 after a review of 78 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1025 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostic Products Corp. devices

FDA 510(k) Submission Details - K840018

510(k) Number K840018 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 05, 1984
Decision Date March 23, 1984
Days to Decision 78 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d faster than avg
Panel avg: 88d · This submission: 78d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CKG Device Classification - Class 2, Special Controls

Product Code CKG Radioimmunoassay, Acth
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CKG Radioimmunoassay, Acth

All 20
Devices cleared under the same product code (CKG) and FDA review panel - the closest regulatory comparables to K840018.
ACTH II BY RADIOIMMUNOASSAY
K850882 · Immuno Nuclear Corp. · Mar 1985
ACTH RIA
K844181 · Syncor Intl. Corp. · Nov 1984
ACTH NORMAL RANGE
K842249 · Diagnostic Systems Laboratories, Inc. · Aug 1984
ACTH RIA
K833849 · Syncor Intl. Corp. · Jan 1984
ADRENOCOR TICOTROPIC HORMONE RADIOIMM
K833471 · Nichols Institute Diagnostics · Jan 1984
ACTH RIA SYSTEM-DSI 2300
K830893 · Diagnostic Systems Laboratories, Inc. · Apr 1983